Formulation, optimization, and evaluation of raft-forming formulations containing Nizatidine

References

• Parente F, Porro GB. Acid inhibitory characteristics of Nizatidine in man: an overview. Scand J Gastroenterol. 2009;27:3–7.
   Google Scholar
• Farheen F, Bharadwaj S. Formulation and evaluation of chewable tablets of mebendazole by different techniques. PharmaTutor Magazine. 2014;2:183–189.
   Google Scholar
• Kathiresan K, Vijin P, Moorthi C, et al. Formulation and evaluation of loratadine chewable tablets. Res J Pharm Biol Chem Sci. 2010;1:763–774.
   Google Scholar
• Gopal V, Patil J, Vishwajith V. Formulation, development and evaluation of chewable tablets containing non-sedating antihistamine. J Pharm Scient Innov. 2012;1:112–117.
   Google Scholar
• Patrick ND. Gastroesophageal reflux disease (GERD): a review of conventional and alternative treatments. Altern Med Rev. 2011;16:116–133.
   PubMedGoogle Scholar
• Philippoz F, Dennett R. Quality by Design (QbD): a quick start guide, 44ème Congrès. International SFSTP – 6 et 7 juin. 2012.
   Google Scholar
• Patel DM, Patel DG, Patel CN. Formulation and optimization of raft forming chewable tablet containing lafutidine. Int J Pharm Sci Drug Res. 2015;7:229–234.
   Google Scholar
• Prajapati ST, Mehta AP, Modhia IP, et al. Formulation and optimization of raft-forming chewable tablets containing H2 antagonist. Int J Pharma Investig. 2012;2:176–182.
   PubMedGoogle Scholar
• Deepika K, Rao AN, Bhavana A, et al. Formulation and evaluation of gastro retentive drug delivery of eprosartan mesylate using raft-forming approach. Int J Adv Pharm Sci. 2014;5:2568–2574.
   Google Scholar
• Ryakala H, Dineshmohan S, Ramesh A, et al. Formulation and in vitro evaluation of bilayer tablets of nebivolol hydrochloride and nateglinide for the treatment of diabetes and hypertension. J Drug Deliv. 2015;2015:1–14.
   Google Scholar
• Basalious EB, El-Sebaie W, El-Gazayerly O. Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets. Am Assoc Pharm Scient. 2011;12:799–810.
   Google Scholar
• Srikanth MV, Sunil SA, Rao NS, et al. Thermal sintering: a novel technique used in the design of gastro retentive floating tablets of propranolol HCl and its statistical optimization using Box-Behnken design. Farmacia. 2012;60:411–435.
   Web of Science ®Google Scholar
• EFSA ANS Panel. EFSA panel on food additives and nutrient sources added to food, Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive. EFSA J. 2013;11:3496.
   Google Scholar
• Patel M, Tolia P, Bhimani B, et al. Formulation and evaluation of raft forming chewable tablet containing pantoprazole sodium. Int J Pharm Res Bio-Sci. 2014;3:580–597.
   Google Scholar
• Prajapati VD, Jani GK, Khutliwala TA, et al. Raft forming system—an upcoming approach of gastro-retentive drug delivery system. J Control Release. 2013;168:151–165.
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Sadeghi H. Shafipour, Biological safety evaluation of stealth solid lipid nanoparticles of risperidone: effect of surface characteristics on their hydrophobicity, haemolysis and macrophage phagocytosis. Farmacia. 2012;60(1):64–79.
   Web of Science ®Google Scholar
• Bhanu PS, Malay KD. Optimization of felodipine nano suspensions using full factorial design. Int J Pharm Technol Res. 2013;5:553–561.
   Google Scholar
• Jagdale S, Ghorpade S, Bhavsar D, et al. Effect of wax on the release pattern of drugs from the sustained release fatty matrix tablet. J Chem Pharm Res. 2010;2:330–338.
   Google Scholar
• British pharmacopoeia. The stationary office. 7th ed. Volume V, Appendix XII and XVII, London, U.K: Cartwright, AC; 2013.
   Google Scholar
• Sarfraz RM, Khan HU, Mahmood A, et al. Formulation and evaluation of mouth disintegrating tablets of atenolol and atorvastatin. Indian J Pharm Sci. 2015;77:83–90.
   PubMed Web of Science ®Google Scholar
• Nalla P, Bagam S, Eedara BB, et al. Formulation and evaluation of domperidone oral proliposomal powders. Int J Pharm Technol Res. 2015;7:108–118.
   Google Scholar
• Vemula SK, Katkum, Liquisolid R. Compact technique for improvement of the dissolution rate of flurbiprofen: formulation and evaluation. J Drug Res Develop. 2015;1:1–5.
   Google Scholar
• Thakur RR, Marwal S. Orally disintegrating preparations: recent advancement in formulation and technology. J Drug Deliv Ther. 2012;2:87–96.
   Google Scholar
• Lakshmi AP, Kumar AB, Kumar AG. Formulation and evaluation of levofloxacin hemihydrate and ambroxol HCl bilayer tablets. Asian J Pharm Clin Res. 2012;5:273–277.
   Google Scholar
• Ali S, Ali J, Ahuja A, et al. Formulation and characterization of dental film containing ofloxacin. J Appl Pharm Sci. 2012;2:114–119.
   Google Scholar
• Patel P, Dave A, Vasava A, et al. Formulation and characterization of sustained release dosage form of moisture sensitive drug. Int J Pharma Investig. 2015;5:92–100.
   PubMed Web of Science ®Google Scholar
• Devkota L, Poudel BK, Silwal JK Formulation and in-vitro evaluation of chewable tablets of montelukast sodium. Int J Drug Deliv Technol. 2015;5:98–103.
   Google Scholar
• Patel A, Modasiya M, Shah D, et al. Development and in vivo floating behavior of verapamil HCl intragastric floating tablets. J Am Assoc Pharm Scient. 2009;10:310–315.
   Google Scholar
• Murthy PN, Mahapatra AK, Nayak TK, et al. Formulation, characterization and drug release kinetics of floating drug delivery systems. J Chem Pharm Res. 2015;7:781–792.
   Google Scholar
• Ramdas TD, Hosmani A, Somwanshi SB. Raft technology for gastro retentive drug delivery. Int J Pharm Pharm Res. 2015;3:232–252.
   Google Scholar
• Chickpetty SM, Raga BV. Formulation, in vitro drug release and in vivo human X-ray investigation of polysaccharide based drug delivery systems for targeting 5-fluorouracil to the colon. Braz J Pharm Sci. 2013;49:263–273.
   Web of Science ®Google Scholar
• Reddy RA, Ramesh B, Kishan V. Drug-excipient interaction during formulation development, in vitro and in vivo evaluation of gastro retentive drug delivery system for Nizatidine. Int J Pharm Sci Nanotechnol. 2013;6:2281–2293.
   Google Scholar
• Qayyum A, Najmi MH, Abbas M. Comparative bioavailability and pharmacokinetics of two oral formulations of flurbiprofen: a single-dose, randomized, open-label, two-period, crossover study in Pakistani subjects. Pak J Pharm Sci. 2013;26:1221–1227.
   PubMed Web of Science ®Google Scholar
• Alswayeh R, Alvi SN, Hammami MM. Rapid determination of amoxicillin levels in human plasma by high performance liquid chromatography. World J Pharm Pharm Sci. 2015;4:1657–1667.
   Google Scholar
• Shao FU, Ankur T, Diana MS, et al. Relevance of rheological properties of sodium alginate in solution to calcium alginate gel properties. J Am Assoc Pharm Scient. 2011;12:453–460.
   Google Scholar
• Dattatraya S, Kailash V, Patil UA, et al. Formulation and evaluation of fast dissolving tablets of Nizatidine. Indian J Novel Drug Deliv. 2014;6:157–172.
   Google Scholar
• Kesavan K, Nath G, Pandit JK. Sodium alginate based mucoadhesive system for gatifloxacin and its in vitro antibacterial activity. Sci Pharm. 2010;78:941–957.
   PubMedGoogle Scholar
• Jagdale SC, Patil SA, Kuchekar BS, et al. Preparation and characterization of metformin hydrochloride-compritol 888 ATO solid dispersion. J Young Pharm. 2011;3:197–204.
   PubMedGoogle Scholar
• Rajbanshi K, Bajracharya R, Shrestha A, et al. Dissolution enhancement of aceclofenac tablet by solid dispersion technique. Int J Pharm Sci Res. 2014;5:127–139.
   Google Scholar
• USP 34 NF 29, The United States Pharmacopiea, the National formulary, volume 2, The United State Pharmacopieal convention, 12601, Rockville, MD: Twinbrook Parkway; 2011. 2587–2588.
   Google Scholar
• Mandal S, Basu SK, Biswanath SA. Sustained release of a water- soluble drug from alginate matrix tablets prepared by wet granulation method. Am Assoc Pharm Scient. 2009;10:1348–1356.
   Google Scholar
• Davies NM, Farr SJ, Kellaway IW, et al. A comparison of the gastric retention of alginate containing tablet formulations with and without the inclusion of excipient calcium ions. Int J Pharm. 1994;105:97–101.
   Web of Science ®Google Scholar
• Krishnan V, Sasikumar S, Dass FP, et al. Effect of pore forming agents on the physical characteristics and release kinetics of levofloxacin hemihydrate from floating alginate drug delivery system - an in vitro study. Trends Biomater Artif Organs. 2010;24:139–145.
   Google Scholar
• Choi BY, Park HJ, Hwang SJ, et al. Preparation of alginate beads for floating drug delivery system: effects of CO2 gas-forming agents. Int J Pharm. 2002;239:81–91.
   PubMed Web of Science ®Google Scholar
• Win CJ, Liao CH, Zhen WC. Evaluation of the drug release mechanism of pH-sensitive calcium alginate hydrogels in simulated physiological fluids. J China Univ Sci Technol. 2010;42:37–61.
   Google Scholar
• Ishak RA. Buoyancy-generating agents for stomach-specific drug delivery: an overview with special emphasis on floating behavior. J Pharm Pharm Sci. 2015;18:77–100.
   PubMed Web of Science ®Google Scholar
• Lokamatha KM, Bharathi A, Kumar SSM, et al. Effect of pvpk30 on complexation and dissolution rate of nevirapine β-cyclodextrin complexes. J Pharm Pharma Sci. 2010;2:169–176.
   Google Scholar
• Kaewnopparat N, Kaewnopparat S, Jangwang A, et al. Increased solubility, dissolution and physicochemical studies of curcumin-polyvinylpyrrolidone K-30 solid dispersions. World Acad Sci Engineer Technol. 2009;31:225–230.
   Google Scholar
• Diaye AN, Jannin V, Berard V, et al. Comparative study of the lubricant performance of Compritol HD5 ATO and Compritol 888 ATO: effect of polyethylene glycol behenate on lubricant capacity. Int J Pharm. 2003;254:263–269.
   PubMedGoogle Scholar
• Mandel KG, Daggy BP, Brodie DA, et al. Alginate-raft formulations in the treatment of heartburn and acid reflux. Alimentary Pharmacol Ther. 2000;14:669–690.
   PubMed Web of Science ®Google Scholar